ImmunoGen, Inc.: accounts_payable
| Value | {"amount": 7809000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2019-06-30) |
| Status | current |
| Entity | ImmunoGen, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f05be06d-c6ea-4ed2-be09-3e1dcc15c5db
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-19-007500 · Open the official SEC filing →Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000855654/accounts-payable/2019-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f05be06d-c6ea-4ed2-be09-3e1dcc15c5db
History
- no predecessors — first report